Want to see TSE:MBX full AI Analyst Report?
Total Valuation
Microbix Biosystms has a market cap or net worth of C$41.25M. The enterprise value is C$41.29M.
Market CapC$41.25M
Enterprise ValueC$41.29M
Share Statistics
Microbix Biosystms has 137,501,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding137,501,160
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Microbix Biosystms’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -4.39%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)-4.39%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee185.85K
Profits Per Employee-22.46K
Employee Count100
Asset Turnover0.50
Inventory Turnover0.95
Valuation Ratios
The current PE Ratio of Microbix Biosystms is ―. Microbix Biosystms’s PEG ratio is 0.10.
PE Ratio―
PS Ratio1.98
PB Ratio1.33
Price to Fair Value1.33
Price to FCF-42.02
Price to Operating Cash Flow-8.76
PEG Ratio0.10
Income Statement
In the last 12 months, Microbix Biosystms had revenue of 18.59M and earned -2.25M in profits. Earnings per share was -0.02.
Revenue18.59M
Gross Profit9.85M
Operating Income-1.58M
Pretax Income-2.30M
Net Income-2.25M
EBITDA428.23K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -4.75M and capital expenditures -741.95K, giving a free cash flow of -5.49M billion.
Operating Cash Flow-4.75M
Free Cash Flow-5.49M
Free Cash Flow per Share-0.04
Dividends & Yields
Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.12
52-Week Price Change1.69%
50-Day Moving Average0.26
200-Day Moving Average0.25
Relative Strength Index (RSI)61.45
Average Volume (3m)57.61K
Important Dates
Microbix Biosystms upcoming earnings date is Aug 13, 2026, TBA (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
Microbix Biosystms as a current ratio of 8.48, with Debt / Equity ratio of 27.03%
Current Ratio8.48
Quick Ratio5.17
Debt to Market Cap0.15
Net Debt to EBITDA-12.47
Interest Coverage Ratio-1.66
Taxes
In the past 12 months, Microbix Biosystms has paid -55.73K in taxes.
Income Tax-55.73K
Effective Tax Rate0.02
Enterprise Valuation
Microbix Biosystms EV to EBITDA ratio is 73.65, with an EV/FCF ratio of -35.94.
EV to Sales1.70
EV to EBITDA73.65
EV to Free Cash Flow-35.94
EV to Operating Cash Flow-392.81
Balance Sheet
Microbix Biosystms has C$8.13M in cash and marketable securities with C$6.80M in debt, giving a net cash position of C$1.33M billion.
Cash & Marketable SecuritiesC$8.13M
Total DebtC$6.80M
Net CashC$1.33M
Net Cash Per Share<C$0.01
Tangible Book Value Per ShareC$0.17
Margins
Gross margin is 42.49%, with operating margin of -8.48%, and net profit margin of -12.08%.
Gross Margin42.49%
Operating Margin-8.48%
Pretax Margin-12.38%
Net Profit Margin-12.08%
EBITDA Margin2.30%
EBIT Margin-7.27%
Analyst Forecast
The average price target for Microbix Biosystms is C$0.40, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.40
Price Target Upside66.67% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-34.81%
EPS Growth Forecast-453.45%